APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Whole Blood and Blood Components

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pet Whole Blood and Blood Components Market Outlook and Growth Opportunities 2026

8 January 2026194 pages

Choose your research edition.

Industry ResearchPet Whole Blood and Blood Components Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Whole Blood and Blood Components Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Pet Whole Blood and Blood Components Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Whole Blood and Blood Components Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Whole Blood and Blood Components Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Pet Whole Blood and Blood Components market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pet Whole Blood and Blood Components is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Whole Blood and Blood Components is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Whole Blood and Blood Components is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pet Whole Blood and Blood Components market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pet Whole Blood and Blood Components market include Thermo Fisher Scientific, Moregate BioTech, Bovogen Biologicals (ANZCO Foods Healthcare), Pel-Freez, LLC, HemoStat Laboratories, CellSera Australia (Auckland BioSciences), Animal Technologies, Serana Europe and Lake Immunogenics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet Whole Blood and Blood Components market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Whole Blood and Blood Components and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Whole Blood and Blood Components sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Whole Blood and Blood Components market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Whole Blood and Blood Components Segment by Company

Thermo Fisher Scientific

Moregate BioTech

Bovogen Biologicals (ANZCO Foods Healthcare)

Pel-Freez, LLC

HemoStat Laboratories

CellSera Australia (Auckland BioSciences)

Animal Technologies

Serana Europe

Lake Immunogenics

MoreCare. Inc.

Nanjing BioChannel Biotechnology Co., Ltd

Pet Whole Blood and Blood Components Segment by Type

Canine

Feline

Bovine

Sheep

Others

Pet Whole Blood and Blood Components Segment by Application

Veterinary Hospital

Clinic

Other

Pet Whole Blood and Blood Components Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pet Whole Blood and Blood Components status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pet Whole Blood and Blood Components market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pet Whole Blood and Blood Components significant trends, drivers, influence factors in global and regions.

6. To analyze Pet Whole Blood and Blood Components competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Whole Blood and Blood Components market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Whole Blood and Blood Components and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Whole Blood and Blood Components.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet Whole Blood and Blood Components market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Whole Blood and Blood Components industry.

Chapter 3: Detailed analysis of Pet Whole Blood and Blood Components manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pet Whole Blood and Blood Components in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pet Whole Blood and Blood Components in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pet Whole Blood and Blood Components Industry Trends Table 2. Pet Whole Blood and Blood Components Industry Drivers Table 3. Pet Whole Blood and Blood Components Industry Opportunities and Challenges Table 4. Pet Whole Blood and Blood Components Industry Restraints Table 5. Global Pet Whole Blood and Blood Components Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pet Whole Blood and Blood Components Revenue Share by Company (2021-2026) Table 7. Global Pet Whole Blood and Blood Components Sales Volume by Company (kL) & (2021-2026) Table 8. Global Pet Whole Blood and Blood Components Sales Volume Share by Company (2021-2026) Table 9. Global Pet Whole Blood and Blood Components Average Price (USD/L) of Company (2021-2026) Table 10. Global Pet Whole Blood and Blood Components Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pet Whole Blood and Blood Components Key Company Manufacturing Base & Headquarters Table 12. Global Pet Whole Blood and Blood Components Company, Product Type & Application Table 13. Global Pet Whole Blood and Blood Components Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet Whole Blood and Blood Components by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Canine Table 18. Significant Companies of Feline Table 19. Significant Companies of Bovine Table 20. Significant Companies of Sheep Table 21. Significant Companies of Others Table 22. Global Pet Whole Blood and Blood Components Sales Volume by Type 2021 VS 2025 VS 2032 (kL) Table 23. Global Pet Whole Blood and Blood Components Sales Volume by Type (2021-2026) & (kL) Table 24. Global Pet Whole Blood and Blood Components Sales Volume by Type (2027-2032) & (kL) Table 25. Global Pet Whole Blood and Blood Components Sales Volume Share by Type (2021-2026) Table 26. Global Pet Whole Blood and Blood Components Sales Volume Share by Type (2027-2032) Table 27. Global Pet Whole Blood and Blood Components Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pet Whole Blood and Blood Components Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Pet Whole Blood and Blood Components Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Pet Whole Blood and Blood Components Sales Value Share by Type (2021-2026) Table 31. Global Pet Whole Blood and Blood Components Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Veterinary Hospital Table 33. Significant Companies of Clinic Table 34. Significant Companies of Other Table 35. Global Pet Whole Blood and Blood Components Sales Volume by Application 2021 VS 2025 VS 2032 (kL) Table 36. Global Pet Whole Blood and Blood Components Sales Volume by Application (2021-2026) & (kL) Table 37. Global Pet Whole Blood and Blood Components Sales Volume by Application (2027-2032) & (kL) Table 38. Global Pet Whole Blood and Blood Components Sales Volume Share by Application (2021-2026) Table 39. Global Pet Whole Blood and Blood Components Sales Volume Share by Application (2027-2032) Table 40. Global Pet Whole Blood and Blood Components Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Pet Whole Blood and Blood Components Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Pet Whole Blood and Blood Components Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Pet Whole Blood and Blood Components Sales Value Share by Application (2021-2026) Table 44. Global Pet Whole Blood and Blood Components Sales Value Share by Application (2027-2032) Table 45. Global Pet Whole Blood and Blood Components Sales by Region: 2021 VS 2025 VS 2032 (kL) Table 46. Global Pet Whole Blood and Blood Components Sales by Region (2021-2026) & (kL) Table 47. Global Pet Whole Blood and Blood Components Sales Market Share by Region (2021-2026) Table 48. Global Pet Whole Blood and Blood Components Sales by Region (2027-2032) & (kL) Table 49. Global Pet Whole Blood and Blood Components Sales Market Share by Region (2027-2032) Table 50. Global Pet Whole Blood and Blood Components Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Pet Whole Blood and Blood Components Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Pet Whole Blood and Blood Components Sales Value Share by Region (2021-2026) Table 53. Global Pet Whole Blood and Blood Components Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Pet Whole Blood and Blood Components Sales Value Share by Region (2027-2032) Table 55. Global Pet Whole Blood and Blood Components Market Average Price (USD/L) by Region (2021-2026) Table 56. Global Pet Whole Blood and Blood Components Market Average Price (USD/L) by Region (2027-2032) Table 57. Global Pet Whole Blood and Blood Components Sales by Country: 2021 VS 2025 VS 2032 (kL) Table 58. Global Pet Whole Blood and Blood Components Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Pet Whole Blood and Blood Components Sales by Country (2021-2026) & (kL) Table 60. Global Pet Whole Blood and Blood Components Sales Market Share by Country (2021-2026) Table 61. Global Pet Whole Blood and Blood Components Sales by Country (2027-2032) & (kL) Table 62. Global Pet Whole Blood and Blood Components Sales Market Share by Country (2027-2032) Table 63. Global Pet Whole Blood and Blood Components Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Pet Whole Blood and Blood Components Sales Value Market Share by Country (2021-2026) Table 65. Global Pet Whole Blood and Blood Components Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Pet Whole Blood and Blood Components Sales Value Market Share by Country (2027-2032) Table 67. Thermo Fisher Scientific Company Information Table 68. Thermo Fisher Scientific Business Overview Table 69. Thermo Fisher Scientific Pet Whole Blood and Blood Components Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 70. Thermo Fisher Scientific Pet Whole Blood and Blood Components Product Portfolio Table 71. Thermo Fisher Scientific Recent Development Table 72. Moregate BioTech Company Information Table 73. Moregate BioTech Business Overview Table 74. Moregate BioTech Pet Whole Blood and Blood Components Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 75. Moregate BioTech Pet Whole Blood and Blood Components Product Portfolio Table 76. Moregate BioTech Recent Development Table 77. Bovogen Biologicals (ANZCO Foods Healthcare) Company Information Table 78. Bovogen Biologicals (ANZCO Foods Healthcare) Business Overview Table 79. Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 80. Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Product Portfolio Table 81. Bovogen Biologicals (ANZCO Foods Healthcare) Recent Development Table 82. Pel-Freez, LLC Company Information Table 83. Pel-Freez, LLC Business Overview Table 84. Pel-Freez, LLC Pet Whole Blood and Blood Components Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 85. Pel-Freez, LLC Pet Whole Blood and Blood Components Product Portfolio Table 86. Pel-Freez, LLC Recent Development Table 87. HemoStat Laboratories Company Information Table 88. HemoStat Laboratories Business Overview Table 89. HemoStat Laboratories Pet Whole Blood and Blood Components Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 90. HemoStat Laboratories Pet Whole Blood and Blood Components Product Portfolio Table 91. HemoStat Laboratories Recent Development Table 92. CellSera Australia (Auckland BioSciences) Company Information Table 93. CellSera Australia (Auckland BioSciences) Business Overview Table 94. CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 95. CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Product Portfolio Table 96. CellSera Australia (Auckland BioSciences) Recent Development Table 97. Animal Technologies Company Information Table 98. Animal Technologies Business Overview Table 99. Animal Technologies Pet Whole Blood and Blood Components Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 100. Animal Technologies Pet Whole Blood and Blood Components Product Portfolio Table 101. Animal Technologies Recent Development Table 102. Serana Europe Company Information Table 103. Serana Europe Business Overview Table 104. Serana Europe Pet Whole Blood and Blood Components Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 105. Serana Europe Pet Whole Blood and Blood Components Product Portfolio Table 106. Serana Europe Recent Development Table 107. Lake Immunogenics Company Information Table 108. Lake Immunogenics Business Overview Table 109. Lake Immunogenics Pet Whole Blood and Blood Components Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 110. Lake Immunogenics Pet Whole Blood and Blood Components Product Portfolio Table 111. Lake Immunogenics Recent Development Table 112. MoreCare. Inc. Company Information Table 113. MoreCare. Inc. Business Overview Table 114. MoreCare. Inc. Pet Whole Blood and Blood Components Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 115. MoreCare. Inc. Pet Whole Blood and Blood Components Product Portfolio Table 116. MoreCare. Inc. Recent Development Table 117. Nanjing BioChannel Biotechnology Co., Ltd Company Information Table 118. Nanjing BioChannel Biotechnology Co., Ltd Business Overview Table 119. Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 120. Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Product Portfolio Table 121. Nanjing BioChannel Biotechnology Co., Ltd Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Pet Whole Blood and Blood Components Distributors List Table 125. Pet Whole Blood and Blood Components Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Pet Whole Blood and Blood Components Product Image Figure 2. Global Pet Whole Blood and Blood Components Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Whole Blood and Blood Components Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pet Whole Blood and Blood Components Sales (2021-2032) & (kL) Figure 5. Global Pet Whole Blood and Blood Components Sales Average Price (USD/L) & (2021-2032) Figure 6. Global Pet Whole Blood and Blood Components Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Canine Image Figure 10. Feline Image Figure 11. Bovine Image Figure 12. Sheep Image Figure 13. Others Image Figure 14. Global Pet Whole Blood and Blood Components Sales Volume by Type (2021 VS 2025 VS 2032) & (kL) Figure 15. Global Pet Whole Blood and Blood Components Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Pet Whole Blood and Blood Components Sales Volume Share by Type (2021-2032) Figure 17. Global Pet Whole Blood and Blood Components Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pet Whole Blood and Blood Components Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pet Whole Blood and Blood Components Sales Value Share by Type (2021-2032) Figure 20. Veterinary Hospital Image Figure 21. Clinic Image Figure 22. Other Image Figure 23. Global Pet Whole Blood and Blood Components Sales Volume by Application (2021 VS 2025 VS 2032) & (kL) Figure 24. Global Pet Whole Blood and Blood Components Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Pet Whole Blood and Blood Components Sales Volume Share by Application (2021-2032) Figure 26. Global Pet Whole Blood and Blood Components Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Pet Whole Blood and Blood Components Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Pet Whole Blood and Blood Components Sales Value Share by Application (2021-2032) Figure 29. Global Pet Whole Blood and Blood Components Sales by Region: 2021 VS 2025 VS 2032 (kL) Figure 30. Global Pet Whole Blood and Blood Components Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Pet Whole Blood and Blood Components Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Pet Whole Blood and Blood Components Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Pet Whole Blood and Blood Components Sales Value (2021-2032) & (US$ Million) Figure 34. North America Pet Whole Blood and Blood Components Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Pet Whole Blood and Blood Components Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Pet Whole Blood and Blood Components Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Pet Whole Blood and Blood Components Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Pet Whole Blood and Blood Components Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Pet Whole Blood and Blood Components Sales Value (2021-2032) & (US$ Million) Figure 40. South America Pet Whole Blood and Blood Components Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Pet Whole Blood and Blood Components Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Pet Whole Blood and Blood Components Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Pet Whole Blood and Blood Components Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Pet Whole Blood and Blood Components Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Canine
  • Feline
  • Bovine
  • Sheep
  • Others
Applications
  • Veterinary Hospital
  • Clinic
  • Other
Companies covered
  • Thermo Fisher Scientific
  • Moregate BioTech
  • Bovogen Biologicals (ANZCO Foods Healthcare)
  • Pel-Freez, LLC
  • HemoStat Laboratories
  • CellSera Australia (Auckland BioSciences)
  • Animal Technologies
  • Serana Europe
  • Lake Immunogenics
  • MoreCare. Inc.
  • Nanjing BioChannel Biotechnology Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pet Whole Blood and Blood Components Sales Value (2021-2032)
  4. 1.2.2 Global Pet Whole Blood and Blood Components Sales Volume (2021-2032)
  5. 1.2.3 Global Pet Whole Blood and Blood Components Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pet Whole Blood and Blood Components Market Dynamics
  1. 2.1 Pet Whole Blood and Blood Components Industry Trends
  2. 2.2 Pet Whole Blood and Blood Components Industry Drivers
  3. 2.3 Pet Whole Blood and Blood Components Industry Opportunities and Challenges
  4. 2.4 Pet Whole Blood and Blood Components Industry Restraints
3 Pet Whole Blood and Blood Components Market by Company
  1. 3.1 Global Pet Whole Blood and Blood Components Company Revenue Ranking in 2025
  2. 3.2 Global Pet Whole Blood and Blood Components Revenue by Company (2021-2026)
  3. 3.3 Global Pet Whole Blood and Blood Components Sales Volume by Company (2021-2026)
  4. 3.4 Global Pet Whole Blood and Blood Components Average Price by Company (2021-2026)
  5. 3.5 Global Pet Whole Blood and Blood Components Company Ranking (2024-2026)
  6. 3.6 Global Pet Whole Blood and Blood Components Company Manufacturing Base and Headquarters
  7. 3.7 Global Pet Whole Blood and Blood Components Company Product Type and Application
  8. 3.8 Global Pet Whole Blood and Blood Components Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pet Whole Blood and Blood Components Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pet Whole Blood and Blood Components Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pet Whole Blood and Blood Components Market by Type
  1. 4.1 Pet Whole Blood and Blood Components Type Introduction
  2. 4.1.1 Canine
  3. 4.1.2 Feline
  4. 4.1.3 Bovine
  5. 4.1.4 Sheep
  6. 4.1.5 Others
  7. 4.2 Global Pet Whole Blood and Blood Components Sales Volume by Type
  8. 4.2.1 Global Pet Whole Blood and Blood Components Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pet Whole Blood and Blood Components Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Pet Whole Blood and Blood Components Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Pet Whole Blood and Blood Components Sales Value by Type
  12. 4.3.1 Global Pet Whole Blood and Blood Components Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Pet Whole Blood and Blood Components Sales Value by Type (2021-2032)
  14. 4.3.3 Global Pet Whole Blood and Blood Components Sales Value Share by Type (2021-2032)
5 Pet Whole Blood and Blood Components Market by Application
  1. 5.1 Pet Whole Blood and Blood Components Application Introduction
  2. 5.1.1 Veterinary Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Pet Whole Blood and Blood Components Sales Volume by Application
  6. 5.2.1 Global Pet Whole Blood and Blood Components Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pet Whole Blood and Blood Components Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pet Whole Blood and Blood Components Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pet Whole Blood and Blood Components Sales Value by Application
  10. 5.3.1 Global Pet Whole Blood and Blood Components Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pet Whole Blood and Blood Components Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pet Whole Blood and Blood Components Sales Value Share by Application (2021-2032)
6 Pet Whole Blood and Blood Components Regional Sales and Value Analysis
  1. 6.1 Global Pet Whole Blood and Blood Components Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Whole Blood and Blood Components Sales by Region (2021-2032)
  3. 6.2.1 Global Pet Whole Blood and Blood Components Sales by Region: 2021-2026
  4. 6.2.2 Global Pet Whole Blood and Blood Components Sales by Region (2027-2032)
  5. 6.3 Global Pet Whole Blood and Blood Components Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pet Whole Blood and Blood Components Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pet Whole Blood and Blood Components Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pet Whole Blood and Blood Components Sales Value by Region (2027-2032)
  9. 6.5 Global Pet Whole Blood and Blood Components Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pet Whole Blood and Blood Components Sales Value (2021-2032)
  12. 6.6.2 North America Pet Whole Blood and Blood Components Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pet Whole Blood and Blood Components Sales Value (2021-2032)
  15. 6.7.2 Europe Pet Whole Blood and Blood Components Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pet Whole Blood and Blood Components Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pet Whole Blood and Blood Components Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pet Whole Blood and Blood Components Sales Value (2021-2032)
  21. 6.9.2 South America Pet Whole Blood and Blood Components Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pet Whole Blood and Blood Components Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pet Whole Blood and Blood Components Sales Value Share by Country, 2025 VS 2032
7 Pet Whole Blood and Blood Components Country-level Sales and Value Analysis
  1. 7.1 Global Pet Whole Blood and Blood Components Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pet Whole Blood and Blood Components Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pet Whole Blood and Blood Components Sales by Country (2021-2032)
  4. 7.3.1 Global Pet Whole Blood and Blood Components Sales by Country (2021-2026)
  5. 7.3.2 Global Pet Whole Blood and Blood Components Sales by Country (2027-2032)
  6. 7.4 Global Pet Whole Blood and Blood Components Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pet Whole Blood and Blood Components Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pet Whole Blood and Blood Components Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pet Whole Blood and Blood Components Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pet Whole Blood and Blood Components Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pet Whole Blood and Blood Components Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Pet Whole Blood and Blood Components Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Pet Whole Blood and Blood Components Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Moregate BioTech
  8. 8.2.1 Moregate BioTech Company Information
  9. 8.2.2 Moregate BioTech Business Overview
  10. 8.2.3 Moregate BioTech Pet Whole Blood and Blood Components Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Moregate BioTech Pet Whole Blood and Blood Components Product Portfolio
  12. 8.2.5 Moregate BioTech Recent Developments
  13. 8.3 Bovogen Biologicals (ANZCO Foods Healthcare)
  14. 8.3.1 Bovogen Biologicals (ANZCO Foods Healthcare) Company Information
  15. 8.3.2 Bovogen Biologicals (ANZCO Foods Healthcare) Business Overview
  16. 8.3.3 Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Product Portfolio
  18. 8.3.5 Bovogen Biologicals (ANZCO Foods Healthcare) Recent Developments
  19. 8.4 Pel-Freez, LLC
  20. 8.4.1 Pel-Freez, LLC Company Information
  21. 8.4.2 Pel-Freez, LLC Business Overview
  22. 8.4.3 Pel-Freez, LLC Pet Whole Blood and Blood Components Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pel-Freez, LLC Pet Whole Blood and Blood Components Product Portfolio
  24. 8.4.5 Pel-Freez, LLC Recent Developments
  25. 8.5 HemoStat Laboratories
  26. 8.5.1 HemoStat Laboratories Company Information
  27. 8.5.2 HemoStat Laboratories Business Overview
  28. 8.5.3 HemoStat Laboratories Pet Whole Blood and Blood Components Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 HemoStat Laboratories Pet Whole Blood and Blood Components Product Portfolio
  30. 8.5.5 HemoStat Laboratories Recent Developments
  31. 8.6 CellSera Australia (Auckland BioSciences)
  32. 8.6.1 CellSera Australia (Auckland BioSciences) Company Information
  33. 8.6.2 CellSera Australia (Auckland BioSciences) Business Overview
  34. 8.6.3 CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Product Portfolio
  36. 8.6.5 CellSera Australia (Auckland BioSciences) Recent Developments
  37. 8.7 Animal Technologies
  38. 8.7.1 Animal Technologies Company Information
  39. 8.7.2 Animal Technologies Business Overview
  40. 8.7.3 Animal Technologies Pet Whole Blood and Blood Components Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Animal Technologies Pet Whole Blood and Blood Components Product Portfolio
  42. 8.7.5 Animal Technologies Recent Developments
  43. 8.8 Serana Europe
  44. 8.8.1 Serana Europe Company Information
  45. 8.8.2 Serana Europe Business Overview
  46. 8.8.3 Serana Europe Pet Whole Blood and Blood Components Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Serana Europe Pet Whole Blood and Blood Components Product Portfolio
  48. 8.8.5 Serana Europe Recent Developments
  49. 8.9 Lake Immunogenics
  50. 8.9.1 Lake Immunogenics Company Information
  51. 8.9.2 Lake Immunogenics Business Overview
  52. 8.9.3 Lake Immunogenics Pet Whole Blood and Blood Components Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lake Immunogenics Pet Whole Blood and Blood Components Product Portfolio
  54. 8.9.5 Lake Immunogenics Recent Developments
  55. 8.10 MoreCare. Inc.
  56. 8.10.1 MoreCare. Inc. Company Information
  57. 8.10.2 MoreCare. Inc. Business Overview
  58. 8.10.3 MoreCare. Inc. Pet Whole Blood and Blood Components Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 MoreCare. Inc. Pet Whole Blood and Blood Components Product Portfolio
  60. 8.10.5 MoreCare. Inc. Recent Developments
  61. 8.11 Nanjing BioChannel Biotechnology Co., Ltd
  62. 8.11.1 Nanjing BioChannel Biotechnology Co., Ltd Company Information
  63. 8.11.2 Nanjing BioChannel Biotechnology Co., Ltd Business Overview
  64. 8.11.3 Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Product Portfolio
  66. 8.11.5 Nanjing BioChannel Biotechnology Co., Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet Whole Blood and Blood Components Value Chain Analysis
  2. 9.1.1 Pet Whole Blood and Blood Components Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet Whole Blood and Blood Components Sales Mode & Process
  6. 9.2 Pet Whole Blood and Blood Components Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet Whole Blood and Blood Components Distributors
  9. 9.2.3 Pet Whole Blood and Blood Components Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst